CO News and Press, Global Cord Blood Corporation From 11/26/21

Global Cord Blood Corporation (CO) Q2 2022 Earnings Conference Call November 26, 2021, 08:00 AM ET Company Participants Cathy Bai - VP of Corporate Finance Albert Chen - CFO Conference Call Participants Jeff Oliver - Star Funds Presentation Operator Welcome everyone to Global Cord Blood Corpo...

Shares of Global Cord Blood Corp. (NYSE:CO) are up 17% after-hours after the company released Q2 2022 earnings results that showed year over year revenue and net income increases. Revenues increased 9.8% to RMB 313.7M ($48.7M). Net income rose ~4.5% to compared to the prior-year per...

AVXL, CO, OTCQX:TGODF For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Wednesday's close

BofA Securities breaks down asset performance for the year and also notes that real rates are at levels more historically associated with panics. In the weekly Flow Show note, Chief Investment Strategist Michael Hartnett and team rank the best and worst places for 2021 returns. Bitcoin (BTC-U...

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2022 Financial Results Earnings Call Scheduled for 8:00 a.m. ET on November 26, 2021 PR Newswire HONG KONG , Nov. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (t...

With the continued spread of the COVID-19 Delta variant in several parts of the world, the healthcare industry continues to command investors’ attention. The industry is also expected to continue growing on the rising demand for treatments for chronic diseases. Thus, we think it could ...

The growing demand for healthcare services amid the COVID-19 pandemic has led to substantial capital inflows to the industry. Moreover, disruptive progress in genomics and smart healthcare is expected to be the next big thing. Given the industry’s solid growth prospects, we think funda...

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021 PR Newswire HONG KONG , Sept. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood...

The shares of continuous glucose monitoring (CGM) device maker Senseonics Holdings (SENS) have soared 343.9% in price year-to-date, driven by social-media-triggered retail trading. But given the medical technology company’s poor financial health and uncertainty surrounding FDA approval...

Global Cord Blood Corporation (CO) Q1 2022 Earnings Conference Call August 31, 2021 08:00 AM ET Company Participants Cathy Bai - VP of Corporate Finance Albert Chen - Chief Financial Officer Presentation Operator Ladies and gentlemen, welcome everyone to Global Cord Blood Corporation Earnings...